Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic iPSC-derived cardiac spheres for severe heart failure
jRCTa032200189Completed
- Sponsor
- Heartseed Inc.
- Start
- Nov 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial in heart failure with reduced ejection fraction (HFrEF) and dilated cardiomyopathy (DCM), sponsored by Heartseed Inc. Primary endpoints: Acute safety and Subacute and chronic safety. Started Nov 2020; status: completed.
02
Conditions
heart failure with reduced ejection fraction (HFrEF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on jRCTa032200189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTa032200189.